{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T01:45:39Z","timestamp":1790214339248,"version":"4.1.0"},"reference-count":18,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","ajconline.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.amjcard.2017.02.040","type":"journal-article","created":{"date-parts":[[2017,3,16]],"date-time":"2017-03-16T20:18:39Z","timestamp":1489695519000},"page":"1862-1865","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"title":["Occurrence and Natural History of Clinically Silent Episodes of Atrial Fibrillation in Hypertrophic Cardiomyopathy"],"prefix":"10.1016","volume":"119","author":[{"given":"Ethan J.","family":"Rowin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Orfanos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.A. Mark","family":"Estes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark S.","family":"Link","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin S.","family":"Maron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry J.","family":"Maron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2017.02.040_bib1","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1002\/ejhf.316","article-title":"Prediction of thrombo-embolic risk in patients with hypertrophic cardiomyopathy (HC Risk-CVA)","volume":"17","author":"Guttmann","year":"2015","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.amjcard.2017.02.040_bib2","doi-asserted-by":"publisher","first-page":"2517","DOI":"10.1161\/hc4601.097997","article-title":"Impact of atrial fibrillation on the clinical course of hypertrophic cardiomyopathy","volume":"104","author":"Olivotto","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2017.02.040_bib3","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/S0735-1097(01)01727-2","article-title":"Clinical profile of stroke in 900 patients with hypertrophic cardiomyopathy","volume":"39","author":"Maron","year":"2002","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2017.02.040_bib4","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1016\/j.amjcard.2013.12.045","article-title":"Left atrial remodeling in hypertrophic cardiomyopathy and susceptibility markers for atrial fibrillation identified by cardiovascular magnetic resonance","volume":"113","author":"Maron","year":"2014","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2017.02.040_bib5","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1111\/jce.12982","article-title":"High incidence of de novo and subclinical atrial fibrillation in patients with hypertrophic cardiomyopathy and cardiac rhythm management device","volume":"27","author":"Wilke","year":"2016","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.amjcard.2017.02.040_bib6","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.amjcard.2016.08.092","article-title":"Incidence of device-detected atrial fibrillation and long-term outcomes in patients with hypertrophic cardiomyopathy","volume":"119","author":"van Velzen","year":"2017","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2017.02.040_bib7","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1111\/jce.13012","article-title":"Silent AF and hypertrophic stroke risk: more data, more monitoring","volume":"27","author":"Winterfield","year":"2016","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.amjcard.2017.02.040_bib8","doi-asserted-by":"publisher","first-page":"e001002","DOI":"10.1161\/JAHA.114.001002","article-title":"Atrial fibrillation in hypertrophic cardiomyopathy: prevalence, clinical correlations, and mortality in a large high-risk population","volume":"3","author":"Siontis","year":"2014","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.amjcard.2017.02.040_bib9","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1253\/circj.CJ-09-0140","article-title":"Clinical impact of atrial fibrillation in patients with hypertrophic cardiomyopathy. Results from Kochi RYOMA Study","volume":"73","author":"Kubo","year":"2009","journal-title":"Circ J"},{"key":"10.1016\/j.amjcard.2017.02.040_bib10","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1161\/STROKEAHA.115.012130","article-title":"Stroke and embolic events in hypertrophic cardiomyopathy: risk stratification in patients without atrial fibrillation","volume":"47","author":"Haruki","year":"2016","journal-title":"Stroke"},{"key":"10.1016\/j.amjcard.2017.02.040_bib11","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1136\/heartjnl-2013-304908","article-title":"Exercise capacity and paroxysmal atrial fibrillation in patients with hypertrophic cardiomyopathy","volume":"100","author":"Azarbal","year":"2014","journal-title":"Heart"},{"key":"10.1016\/j.amjcard.2017.02.040_bib12","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1093\/eurheartj\/ehi825","article-title":"Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study","volume":"27","author":"Heeringa","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2017.02.040_bib13","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.jacc.2014.03.022","article-title":"2014 AHA\/ACC\/HRS guideline for the management of\u00a0patients with atrial fibrillation","volume":"64","author":"January","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2017.02.040_bib14","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1056\/NEJMoa1105575","article-title":"Subclinical atrial fibrillation and the risk of stroke","volume":"366","author":"Healy","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.amjcard.2017.02.040_bib15","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1001\/jamacardio.2016.5167","article-title":"The role of cardiovascular implantable electronic devices in the detection and treatment of subclinical atrial fibrillation: a Review","volume":"2","author":"Hess","year":"2017","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.amjcard.2017.02.040_bib16","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.jacc.2014.10.045","article-title":"Device-detected atrial fibrillation: what to do with asymptomatic patients?","volume":"65","author":"Chen-Scarabelli","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2017.02.040_bib17","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehx042","article-title":"Duration of device-detected subclinical atrial fibrillation and occurrence of stroke in ASSERT [Epub ahead of print]","author":"Van Gelder","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2017.02.040_bib18","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1038\/nrcardio.2017.6","article-title":"Shared decision making in HCM","volume":"14","author":"Maron","year":"2017","journal-title":"Nat Rev Cardiol"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914917302758?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914917302758?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,3]],"date-time":"2018-09-03T13:21:27Z","timestamp":1535980887000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914917302758"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":18,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["S0002914917302758"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2017.02.040","relation":{},"ISSN":["0002-9149"],"issn-type":[{"value":"0002-9149","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Occurrence and Natural History of Clinically Silent Episodes of Atrial Fibrillation in Hypertrophic Cardiomyopathy","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjcard.2017.02.040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}